Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2

See allHide authors and affiliations

Science  01 Mar 2002:
Vol. 295, Issue 5560, pp. 1726-1729
DOI: 10.1126/science.1069094


The gastrointestinal tract is lined by a layer of mucus comprised of highly glycosylated proteins called mucins. To evaluate the importance of mucin in intestinal carcinogenesis, we constructed mice genetically deficient in Muc2, the most abundant secreted gastrointestinal mucin. Muc2−/− mice displayed aberrant intestinal crypt morphology and altered cell maturation and migration. Most notably, the mice frequently developed adenomas in the small intestine that progressed to invasive adenocarcinoma, as well as rectal tumors. Thus, Muc2 is involved in the suppression of colorectal cancer.

Mucins are highly glycosylated proteins that are the major component of the mucus that lubricates and protects underlying intestinal epithelium (1). Alterations of mucin expression and glycosylation have been observed in human colon cancer specimens (2), but the role of these proteins in tumorigenesis remains unclear. To evaluate the importance of mucin in the early stages of intestinal carcinogenesis, we generated mice genetically deficient in Muc2, the most abundant secreted gastrointestinal apomucin, which is the unglycosylated form of mucin (3, 4). Targeted inactivation of the Muc2 gene was achieved by replacing a genomic fragment (5) harboring exons 2 to 4 of Muc2 with aphosphoglycerate kinase-neomycin (PKG-Neo) cassette (6). Six independent clones were identified by Southern blot analysis (6), displaying the appropriate recombinant event. Muc2 +/−F1 progeny from two independently generated male chimeric mice were back-crossed to obtain F2 mice of all three genotypes in the expected Mendelian ratio. These (C57BL/6J × 129/SvOla) F2 to F5 mice were used in the experiments described here. Heterozygous mice were indistinguishable from wild-type mice.

A probe specific for sequences downstream of the recombination event detected the characteristic polydisperse profile ofMuc2 messenger RNA (mRNA) in different portions of the intestine of Muc2 wild-type mice (6). However, upon overexposure of the blot, the probe detected a similar band in the intestine of Muc2 −/− mice. Further analysis demonstrated that this transcript was a hybridMuc2-Neo mRNA, predicted to encode an 83 amino acid (aa) peptide containing the first 26 aa of the Muc2 apoprotein (6). In agreement with the prediction, a polyclonal antibody (PH497) against deglycosylated gastrointestinal mucin stained goblet cells in the intestine of wild-type but notMuc2 −/− mice (Fig. 1A) (6). Thus,Muc2 −/− is a null mouse. Consistent with this, Alcian blue staining of acidic mucins in sections of the duodenum and the proximal and distal colon showed absence of recognizable goblet cells along the entire length of the intestine ofMuc2 −/− mice (Fig. 1B) (6). The distal colon of Muc2 −/− mice showed residual light-blue staining toward the bottom of the crypt, but this pattern was distinct from that seen in wild-type mice.

Figure 1

Absence of Muc2 apomucin and alteration of cell maturation in the Muc2 −/−intestine. Sections from proximal colon of wild-type andMuc2 −/− mice were stained in (A) with the polyclonal antibody PH497 that recognizes Muc2, in (B) with Alcian blue to identify goblet cells, and in (C) with a polyclonal antibody anti-Itf. (D andE) Immunohistochemical detection of BrdU-labeled cells in the intestine of wild-type and Muc2 −/− mice. Mice, injected with BrdU, were killed 2 hours after injection to determine the number of cells in S phase or 24 and 48 hours after BrdU injection to determine the rate of migration. Sections from the duodenum (D) or the distal colon (E) were stained with antibody to BrdU. Bars: (A) through (D), 25 μm; (E), 100 μm.

The absence of goblet cells was not due to complete ablation of the differentiation pathway of this lineage because we could detect expression of intestinal trefoil factor (Itf), another product of fully differentiated goblet cells (7), by immunohistochemistry in cells that lacked the goblet cell morphology at a similar location in the intestine of both the homozygous mutant and the wild-type mice (Fig. 1C) (6). This suggests that at least some aspects of the differentiation program of the goblet cell lineage persist in Muc2 −/− mice. As assessed by RNA analysis and immunohistochemistry (6), there was no compensatory increase in expression of other apomucins (e.g.,Muc5ac, Muc3, and Muc13) (8–10) in the intestine ofMuc2 −/− mice.

Muc2−/− mice gained weight at the same rate as their heterozygous and wild-type littermates up to 12 months of age (11). However, random testing revealed occult fecal blood in some of the 6-month-old Muc2−/− mice. Wild-type and Muc2−/− mice were killed at 6 months and 1 year of age, and it was found thatMuc2−/− animals had developed gastrointestinal tumors. At the age of 1 year, 65% of theMuc2−/− mice had tumors (Table 1) with a frequency of >1.5 tumors per mouse. In young mice, tumors were restricted to the small intestine, whereas in older mice tumors also appeared in the large intestine (Table 1), including the rectum. No tumors were detected in the stomach, where Muc2 is not normally expressed.

Table 1

Tumor incidence and frequency in the gastrointestinal tract of Muc2 mice. Tumor incidence in wild-type andMuc2 −/− mice was compared using the Mantel-Haenszel test, stratifying according to age at killing (6 month and 1 year). The risk of tumors was significantly greater inMuc2 −/− than wild-type mice (odds ratio 8.956,P < 0.0001, Mantel-Haenszel test, StatXact, Cytel Software, Cambridge, MA). n, number of mice studied. Asterisk indicates mean ± SD.

View this table:

Histopathological analysis revealed that the tumors were of epithelial origin and represented multiple stages of tumor progression. In mice younger than 6 months, tumors were classified as villous (n = 2), tubovillous (n = 1), and tubular adenomas (n = 1). In older mice, the majority of the adenomas had progressed to invasive carcinomas (eight early and one advanced adenocarcinoma). In addition, 3 of 19 (15.7%) ofMuc2 −/− mice developed rectal tumors. Figure 2 shows examples of the gross pathology and histopathology of the adenocarcinomas in duodenum and rectum and an adenoma in the colon.

Figure 2

Histopathology of tumors inMuc2 −/− mice. (A) Gross pathology of a tumor in the duodenum (black arrow); histopathological features of adenocarcinoma shown in (A-1) and (A-2). (B) Adenoma of the colon; histopathological features shown in (B-1) and (B-2). (C) Adenocarcinoma of the rectum; histopathological features shown in (C-1) and (C-2) . Small arrow, rectum; large arrow, tumor. Bars: (A-1) through (C-1), 250 μm; (A-2) through (C-2), 100 μm.

To investigate the cellular mechanism by which inactivation of the Muc2 gene caused tumor formation, we examined whether proliferation and rate of cell migration were altered inMuc2 −/− mice compared with wild-type littermates. Mice were injected with bromodeoxyuridine (BrdU) and killed 2, 24, or 48 hours later (6). At 2 hours after BrdU injection, Muc2 −/− mice exhibited a higher labeling index than wild-type mice in the duodenum [34.5%, (27.3 to 41.7, confidence intervals) inMuc2 −/− versus 24.9%, (9.9 to 39.9) in wild-type mice; P < 0.068], the proximal colon [19.1%, (12.9 to 25.3), versus 10.9%, (2.8 to 19); P< 0.05], and the distal colon [15.6%, (6.0 to 25.2) versus 6.5%, (0.8 to 12.2); P < 0.05] (Fig. 1, D and E). The increased cell proliferation was accompanied by significant decreases in the percentage of apoptotic cells, measured by the Tunel assay, in the duodenum [0.58%, (0.2 to 1) in Muc2 −/−versus 1.75%, (1 to 2.4) in wild-type mice], the proximal colon [0.43, (0.3 to 0.6) versus 1.22, (0.7 to 1.7)], and the distal colon [0.25, (0.1 to 0.4) versus 0.57, (0.4 to 0.8); in each case,P < 0.01]. Thus, the ratio of proliferating to apoptotic cells was highly elevated in the intestine ofMuc2 −/− mice. Furthermore, both proximal and distal colon of Muc2 −/− mice displayed considerably elongated crypts as a result of an increased number of cells per crypt column (proximal colon, 18.2 ± 3.7 inMuc2 −/− versus 12.9 ± 3.1 inMuc2 +/+; distal colon, 29.7 ± 2.4 versus 20.8 ± 3.1; P < 0.01).

To assess the rate of migration of epithelial cells, we examined the fate of BrdU-labeled cells at 24 and 48 hours after BrdU injection. In the duodenum of wild-type mice, the majority of the cells had accumulated at the crypt-villous junction 24 hours after BrdU labeling (Fig. 1D). In contrast, in Muc2 −/−mice, a large number of BrdU+ cells had migrated into the proximal portion of the villous. Within 48 hours, all the BrdU+ cells had been shed from the villi ofMuc2 −/− mice, whereas the majority of labeled cells were still present in the villi of wild-type mice (Fig. 1D). Similarly, at 24 hours the leading edge of BrdU+ cells was much higher up in the crypts of the distal colon ofMuc2 −/− mice, and within 48 hours positive cells were detected at the top of the crypts. In contrast, BrdU+ cells had migrated only three-quarters of the crypt length of the wild-type mice (Fig. 1E). Thus, epithelial cells migrated faster in the intestinal mucosa of Muc2 −/−mice compared with wild-type mice.

Perturbation of the adenomatous polyposis coli (APC)–β-catenin pathway, as detected in familial adenomatous polyposis (FAP) patients and in the majority of sporadic colon cancers (12), results in nuclear accumulation of β-catenin and transcription of target genes includingc-myc and cyclin D1 (13, 14). Accordingly, tumors from Apc1638 mice (15) showed strong nuclear expression of β-catenin and c-Myc (6), whereas tumors inMuc2 −/− mice displayed a strong c-Myc signal that was not accompanied by alterations in the levels and distribution of β-catenin (6). The alteration of c-Myc expression was specific for tumor cells because the pattern of c-Myc in the normal intestinal mucosa of wild-type and mutant mice was not markedly different (6). These results were confirmed by Western blot analysis (6).

In summary, our data demonstrate that Muc2 functions in intestinal homeostasis and that its absence induces alterations that are manifested as increased proliferation, decreased apoptosis, and increased migration of intestinal epithelial cells. These alterations may be a secondary response to the absence of adequate protection and lubrication and/or a primary response to changes in Muc2 signaling. Inactivation of Muc2 causes intestinal tumor formation with spontaneous progression to invasive carcinoma, and this occurs in the absence of the overt inflammatory response seen in other mouse models (16–18). The formation of rectal tumors also distinguishes the Muc2 −/− mouse from previous rodent models of intestinal tumorigenesis, and this mouse may represent a useful model to study human rectal cancers, which are clinically distinct entities of cancer (19). The reduced representation of goblet cells is characteristic of many aberrant crypt foci (ACF) of both humans and rodents (20, 21), which are considered early preneoplastic lesions (22–24). Our data support the hypothesis that the reduction in these cells and, thus, reduction of the mucus they produce, plays a role in tumor formation. Lastly, this work suggests that analysis of MUC2 expression may provide clinically useful information for prognosis and prevention of human colorectal cancer.

  • * To whom correspondence should be addressed. E-mail: velcich{at}


Stay Connected to Science

Navigate This Article